DIA
NXTM

Denver Investment Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Denver Investment Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20,230
Closed -$530K – 505
2016
Q4 		$530K Buy
+20,230
New +$500K 0.02% 333
2016
Q2 		– Sell
-10,190
Closed -$153K – 494
2016
Q1 		$153K Buy
+10,190
New +$171K 0.01% 414

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Denver Investment Advisors's NXTM Position: Q1 2017 in Review

Denver Investment Advisors sold out of NxStage Medical Inc. (NXTM) in Q1 2017, closing a stake of 20,230 shares — an estimated $530K sold.

Denver Investment Advisors first reported a position in NXTM in Q1 2016 and held it in 2 quarters. The position peaked at $530K in Q4 2016. 171 funds tracked by Wall St. Rank hold NXTM as of Q1 2017.

  • Denver Investment Advisors reported no remaining NxStage Medical Inc. position as of Q1 2017 after selling out during the quarter.
  • Denver Investment Advisors sold 20,230 NxStage Medical Inc. shares in Q1 2017, an estimated $530K.
  • Denver Investment Advisors first reported a position in NxStage Medical Inc. in Q1 2016 and held it in 2 quarters.
  • Denver Investment Advisors's NxStage Medical Inc. position peaked at $530K in Q4 2016.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2017.

Based on Denver Investment Advisors's 13F filing for Q1 2017, filed 5 May 2017.